Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
KYTHERA BIOPHARMACEUTICALS INC (KYTH)
|
|
| Balance Sheet |
|
|
|
| Standardized | As Reported |
Annual | Quarterly |
|
| In millions, except per share items | Jun-30-15 | Mar-31-15 | Dec-31-14 | Sep-30-14 | Jun-30-14 | Mar-31-14 | Dec-31-13 | Sep-30-13 |
| | 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 10-Q | 10-K | 10-Q |
| Assets |
| Cash and equivalents | 92.3 | 165.9 | 29.2 | 39.7 | 83.6 | 93.2 | 111.5 | 25.2 |
| Short-term investments | 92.5 | 45.8 | 70.4 | 77.7 | 51.1 | 58.2 | 55.5 | 28.9 |
| Inventories | 4.0 | | | | | | | |
| Other current assets | 3.6 | 1.3 | 1.5 | 1.6 | 2.3 | 3.7 | 6.2 | 10.4 |
| Total current assets | 192.5 | 212.9 | 101.2 | 119.1 | 137.0 | 155.1 | 173.3 | 64.5 |
| Property, plant, and equipment, net | 2.1 | 1.9 | 1.8 | 1.9 | 0.8 | 0.1 | 0.1 | 0.1 |
| Other fixed assets | 0.9 | 0.4 | 0.4 | 0.8 | 0.9 | 0.4 | 0.0 | 0.0 |
| Total assets | 195.4 | 215.3 | 103.4 | 121.7 | 138.8 | 155.6 | 173.4 | 64.6 |
| |
| Accounts payable | 5.6 | 7.4 | 4.7 | 3.0 | 2.2 | 3.2 | 3.2 | 1.5 |
| Accrued expenses | 9.9 | 3.1 | 4.9 | 3.2 | 2.3 | 2.9 | 3.2 | 5.7 |
| Short-term and curr portion of long-term debt [+] | 0.0 | 4.5 | 5.5 | 5.9 | 5.8 | 5.7 | 5.5 | 5.4 |
| Short-term debt | | 4.5 | 5.5 | 5.9 | 5.8 | 5.7 | 5.5 | 5.4 |
| Current portion of long-term debt | | 4.5 | | 5.9 | 5.8 | 5.7 | | |
| Other current liabilities | 8.2 | 4.5 | 5.6 | 5.2 | 3.7 | 1.9 | 5.6 | 7.6 |
| Total current liabilities | 23.7 | 19.5 | 20.6 | 17.4 | 14.0 | 13.7 | 17.6 | 20.2 |
| Long-term debt | 24.6 | 24.4 | 22.7 | 23.5 | 30.6 | 26.2 | 6.0 | 7.4 |
| Other liabilities | 0.6 | 0.7 | 0.7 | 0.6 | -5.3 | 0.0 | 0.0 | 0.0 |
| Total liabilities | 49.0 | 44.6 | 44.0 | 41.5 | 39.3 | 39.8 | 23.6 | 27.6 |
| |
| Shareholders' equity [+] | 146.5 | 170.7 | 59.4 | 80.3 | 99.5 | 115.8 | 149.8 | 37.0 |
| Paid-in capital | 520.4 | 507.3 | 367.3 | 363.9 | 360.6 | 357.5 | 322.1 | 195.2 |
| Retained earnings | -373.8 | -336.7 | -307.8 | -283.6 | -261.1 | -241.7 | -172.2 | -158.2 |
| Tangible shareholders' equity | 146.5 | 170.7 | 59.4 | 80.3 | 99.5 | 115.8 | 149.8 | 37.0 |
|